Insider Transactions Reported by 18 Insiders of NeuroPace Inc

Symbol
NPCE on Nasdaq
Location
Mountain View, CA

Insiders trading volume in the past year

NeuroPace Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Uri Geiger Director $63,844,150 19 Dec 2025
ORBIMED ADVISORS LLC 10%+ Owner $51,616,892 -$2,665,333 -4.9% 14 May 2025
Accelmed Partners II L.P. 10%+ Owner $44,878,722 21 Nov 2022
Frank M. Fischer Director $9,843,693 19 Dec 2025
Michael Favet Chief Executive Officer, Director $4,121,237 21 Feb 2023
JOSEPH LACOB Director $3,438,417 19 Dec 2025
Rebecca Kuhn Chief Financial Officer $1,782,040 03 Jun 2025
Joel Becker CHIEF EXECUTIVE OFFICER, Director $1,700,919 27 Nov 2025
Irina Ridley Chief Legal Officer/Secretary $1,428,877 20 Feb 2023
Martha Morrell Chief Medical Officer $1,311,708 -$1,127,376 -46% 03 Dec 2025
Patrick F. Williams Chief Financial Officer $646,051 20 Jun 2025
Rakhi Kumar Director $298,736 19 Dec 2025
KCK LTD. 10%+ Owner $0 -$49,545,943 -100% 20 Feb 2025
Renee Ryan Director 06 Jun 2025
Lisa Andrade Director 06 Jun 2025
Evan Norton Director 21 Apr 2021
Greg Shaw Garfield Director 13 Jun 2022
R. Scott Huennekens Director 06 Jun 2025

Recent Insider Transactions by Companies or Individuals for NeuroPace Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.